Abstract: A method is described for preparing a mixture for quality control of 0.1 g glycine tablets for sublingual application. The mixture for quality control includes a 100:1 ratio of water to porphyrized tablets, each tablet containing 0.101 g microcapsules of non-agglomerated crystals of amino-acetic acid covered with polymeric film of water-soluble methylcellulose, each tablet further comprising 0.001 g magnesium stearate. The process of dissolution takes 20 minutes and is carried out at a temperature of 37° C. in an apparatus using a paddle rotation speed of 150 revolutions per minute. After the mixture is dissolved, it is allowed to stand for 10 minutes, then a light transmission coefficient is measured at 700±2 nm for a 10 mm thick layer of the mixture. A transmission value within the range of 50% to 70% compared to purified water corresponds to the proper quality.

Abstract: The invention relates to the chemical-pharmaceutical industry and specifically to mix for quality control of the medicine “Glycine tablets for sublingual applying 0.1” and its preparation method. The method involves process of analysis by dissolution of 2.5 g of porphyrized tablets in 250 ml of purified water and light transmission spectrophotometer examination at a wave length of 700±2 in a cuvet with layer thickness of 10 mm relative to purified water Process of dissolution takes 20 minutes and is carried out at a temperature of 370° C. in the apparatus for dissolving determination at a paddle rotation speed of 150 rpm. After mix is dissolved it is allowed for 10 minutes then there are selected 4 ml for light transmission analysis. Mix for quality control includes water in a ratio 100:1 to porphyrized tablets, containing in one tablet 0.101 g microcapsules of non-agglomerated crystals of amino-acetic acid covered with polymeric film of water-soluble methylcellulose, MC-100 and 0.001 g of magnesium stearate.

Abstract: A pharmaceutical composition having an antialcoholic and nootropic effect which is administered sublingually. The active ingredients of the composition are the amino acid L-threonine or a pharmaceutically acceptable salt thereof and vitamin B.sub.6. A method for reducing and eliminating the pathological attraction to alcohol and treatment of alcohol abstinence syndrome, as well as a method for increasing attention comprises sublingual administration of an effective amount of the composition.

Abstract: A pharmaceutical preparation of antistress, stress-protective and nootropic effect contains an effective substance represented by an amino-acid glycine or its pharmaceutically acceptable salt.A method of prophylaxis and curing of stress states and also increasing mental workability consists in sublingually administering an effective amount of the preparation of patent protection sought.

Abstract: A pharmaceutical preparation of antistress, stress-protective and nootropic effect contains an effective substance represented by an amino-acid glycine or its pharmaceutically acceptable salt.A method of prophylaxis and curing of stress states and also increasing mental workability consists in sublingually administering an effective amount of the preparation of patent protection sought.